Status:
COMPLETED
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Gastric Cancer
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to establish a neuroendocrine tumor registry. A registry is a collection of information. To create this registry, the investigators would like to get information, blood an...
Eligibility Criteria
Inclusion
- Diagnosis of gastroenteropancreatic neuroendocrine tumors or neuroendocrine tumors of unknown primary
- Willing to donate blood samples
- \>= 18years old
- Patients may have received prior hormonal therapy, cytotoxic therapy, irradiation, immunotherapy or surgical therapy
Exclusion
- Have any condition, which in the opinion of the primary MSKCC clinician or investigators precludes their ability to provide informed consent
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
238 Patients enrolled
Trial Details
Trial ID
NCT00745381
Start Date
August 1 2008
End Date
July 30 2020
Last Update
August 4 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center at Basking Ridge
Basking Ridge, New Jersey, United States
2
Memorial Sloan-Kettering Cancer Center at Commack
Commack, New York, United States
3
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065